Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Published Date: 18 Oct 2024

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Q&A: When will individuals be able to receive customized cancer vaccines?

3.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

4.

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

5.

Heavy Cannabis Use Tied to Increased Head and Neck Cancer Risk


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot